Navigation Links
Delisting Notification Received from the American Stock Exchange
Date:5/30/2008

Company to evaluate appeal options

TORONTO, May 30 /PRNewswire-FirstCall/ - Predictive medicine company PreMD Inc. (TSX: PMD; Amex: PME) today announced it has been notified by the American Stock Exchange (the "AMEX") that it will not continue to support PreMD's plan for regaining compliance with the continued listing standards and that it intends to delist the Company's common stock from the Exchange by filing a delisting application with the Securities and Exchange Commission (the "SEC") pursuant to Section 1009(d) of the AMEX Company Guide (the "Company Guide"). The determination by the staff of the AMEX to initiate the delisting of the common stock from the AMEX is based on the Company's failure to meet several of the Exchange's conditions for continued listing.

Presently, the Company continues to be noncompliant with Sections 1003(a)(i), 1003(a)(ii), and 1003(a)(iii) of the Company Guide, all of which relate to the Company's insufficient stockholder's equity as previously reported in the Company's filings with the SEC. The AMEX also cites deficiencies regarding the Company's ongoing losses and low share price as additional reasons for the staff's determination. The Company is currently evaluating its options in dealing with the AMEX and will provide updates as they become available. It is management's view that PreMD's delisting on the AMEX does not affect its current listing on the Toronto Stock Exchange (the "TSX").

About PreMD Inc.

PreMD Inc. is a leader in predictive medicine, dedicated to developing rapid, non-invasive tests for the early detection of life-threatening diseases. PreMD's cardiovascular products include a line of non-invasive skin cholesterol tests. PreMD's other skin cholesterol products include PREVU(x) LT, a skin cholesterol test designed for use in the life insurance industry. The Company's cancer tests include ColorectAlert(TM), LungAlert(TM) and a breast cancer test. PreMD's head office is located in Toronto, Ontario and its research and product development facility is at McMaster University in Hamilton, Ontario. For more information about PreMD, please visit http://www.premdinc.com.


'/>"/>
SOURCE PreMD Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. XTL Announces Delisting From the Official List of the United Kingdom Listing Authority
2. HEI, Inc. Initiates Delisting and Deregistration of Its Shares on NASDAQ
3. QMed, Inc. Receives NASDAQ Delisting Letter
4. Vion Pharmaceuticals to Appeal Nasdaq Delisting
5. WorldHeart Notified of TSX Delisting Review
6. WorldHeart Announces Possible Delisting Action by NASDAQ
7. American Academy of Dermatology Association Commends President Bush for Signing Tanning Accountability and Notification (TAN) Act
8. AMICAS Transforms Critical Results Notification with RadStream
9. Merge Technologies Receives Expected Additional NASDAQ Notification
10. Memory Pharmaceuticals Receives Nasdaq Notification Related to Minimum Bid Price
11. IDM Pharma Receives Notification from NASDAQ Relating to Minimum Bid Price
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... (PRWEB) , ... January 23, 2017 , ... “Crossing the ... last ten minutes of a woman’s life. “Crossing the Bar” is the creation of ... of three children. , Charlotte, who credits the inspiration of the book to ...
(Date:1/23/2017)... ... ... Under Blankets”: an entrancing story about one woman's travels through the wilderness of ... published author, Kimberly Mitchell, who earned her bachelor’s degree in English education at the ... degree in education in the field of curriculum and instruction. Kimberly’s passion for writing ...
(Date:1/23/2017)... ... 2017 , ... Valentine’s Day is a time when many people celebrate romance and love by ... be looking for the ideal present, Atlanta-based Perimeter Plastic Surgery is offering a ... Or, spend $200 and get $50 free. , “A lot of people just buy ...
(Date:1/22/2017)... ... January 22, 2017 , ... Zifam Pinnacle, an Australian ... world, recently met with big-name retail buyers at the January ECRM Trade Show in ... and uses the utmost safety standards in all of its creations to help create ...
(Date:1/22/2017)... ... ... Medical lab testing through hospitals and other traditional methods can be ... days to arrive to the end customer, having to travel through medical records and ... bypassing the cost and delay of traditional means. Now all employees of the Frisco ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... Longer life expectancy and rising healthcare expenditure in developing countries ... technologies. BCC Research reveals in its new report that markets ... should see strong growth due to rising government healthcare spending, increased levels ... Continue Reading ... ...
(Date:1/23/2017)... Spain , January 23, 2017 ... clinical-stage biopharmaceutical company focused on treatments for calcification ... been enrolled in the Phase IIb "CaLIPSO Study" ... treatment of cardiovascular calcification (CVC) in end-stage-renal-disease (ESRD) ... patients, in the last stage of chronic kidney ...
(Date:1/22/2017)... DHABI , Saudi Arabia , January 22, 2017 /PRNewswire/ ... the US and UAE ... , at the World Economic Forum   "The ... driven by big data and powered by artificial intelligence and this trend is ... discussed the ,Hospital of the Future, at the concluding day of the 47 ...
Breaking Medicine Technology: